Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of different doses of H018 ointment for atopic dermatitis
CTR20253018Phase 2Active
- Sponsor
- 江苏柯菲平医药股份有限公司
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of H018 ointment in atopic dermatitis (AD), sponsored by 江苏柯菲平医药股份有限公司. Started Sep 2025; status: active.
02
Drugs
H018 ointment
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20253018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253018.